
Money Talks : Global food supply is at risk and these fertiliser stocks are well-placed to capitalise
MoneyTalks is Stockhead’s regular recap of the ASX stocks, sectors and trends that fund managers and analysts are looking at right… Read more
Canary Capital offers high conviction private placements in micro and small Cap companies to Sophisticated and Experienced investors. We also offer all investors access to IPOs and general share trading services.
Learn MoreCapital raising and boutique corporate advisory services for early stage and emerging companies. We fund all business growth stages from Angel and Venture Capital to IPOs and private placements.
Learn MoreReNerve Ltd
ReNerve is developing a portfolio of tissue-based nerve repair products that are designed to be cleaner and safer than current alternatives. The products being developed by ReNerve are targeting the repair and/or replacement of peripheral nerves that have been injured following trauma, malignancy or surgery targeting better outcomes for patients.
ReNerve has 3 products in development. The most advanced product is the NerveAlign Nerve Cuff. It protects nerves and promotes regeneration and incorporates eCOO technology and has recently been approved by the USA FDA. The second product in development is the NerveAlign Nerve Graft. It is an off the shelf nerve graft for the replacement of damaged nerves without surgeons having to harvest nerves. The third product in development is the NerveAlign Bionic. This product combines Nerve Graft with Ionic Polymers that repair large sections of damages nerves.
HTG – RIS – Remote Inspection System
Harvest Technology Group’s Remote Inspection System (RIS) has been launched into the global market. The software allows reliable and secure livestreaming of high-definition video and data from anywhere in the world to manage organisations’ equipment, people, and processes remotely. The software cuts data usage on existing networks by up to 80%, eliminate bottlenecks, increases safety, and innovates in ways that will transform the way business is run whilst delivering operational cost savings of up to 50%. RIS will continue to work even on the most congested and unreliable networks meaning it can be deployed anywhere, including the most challenging locations on the planet.
Sign up and get our latest insights to help with your wealth success.
Our founders have a wealth of experience in the equity capital markets and a track record of delivering superior investor returns. The key to our outperformance is our thorough due diligence when selecting opportunities as well as our willingness to work with management to help them achieve long term success.
We are specialists in micro and small cap stocks across multiple industries. We work with a range of select brokers and institutions in all major Australian capital cities. Family offices, micro cap and small cap fund managers also directly invest in our opportunities.
We only invest in businesses which we believe are high quality emerging Australian companies. We work with management who are experienced leaders in their field and have a track record of delivering value for shareholders. Once funded, we monitor these businesses and work with them to help ensure they stay on course.
MoneyTalks is Stockhead’s regular recap of the ASX stocks, sectors and trends that fund managers and analysts are looking at right… Read more
A pro-rata non-renounceable offer to Eligible Shareholders of one Loyalty Option (Loyalty Option) for every 15 Shares held on the… Read more
Nyrada Inc (ASX: NYR) is pleased to provide shareholders and the market generally with the attached presentation ahead of a… Read more